Bolt Biotherapeutics, Inc. Common Stock, Capital Shares Reserved for Future Issuance
Bolt Biotherapeutics, Inc. (BOLT) had Common Stock, Capital Shares Reserved for Future Issuance of 818.00 thousand shares as of 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Notes › Stockholders' Equity Note
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-03-12
- 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 818.00K shares.
- 2024-12-31: Common Stock, Capital Shares Reserved for Future Issuance 14.03M shares.
- 2023-12-31: Common Stock, Capital Shares Reserved for Future Issuance 11.97M shares.
- 2022-12-31: Common Stock, Capital Shares Reserved for Future Issuance 10.02M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance |
|---|---|
| 2025-12-31 | 818.00K shares 10-K · filed 2026-03-12 |
| 2024-12-31 | 14.03M shares 10-K · filed 2025-03-24 |
| 2023-12-31 | 11.97M shares 10-K · filed 2024-03-21 |
| 2022-12-31 | 10.02M shares 10-K · filed 2023-03-29 |
| 2021-12-31 | 8.69M shares 10-K · filed 2022-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |